Literature DB >> 17359969

Antisense targeting of TGF-beta1 augments BMP-induced upregulation of osteopontin, type I collagen and Cbfa1 in human Saos-2 cells.

Zhong-Jian Shen1, Sang Kook Kim, Do Youn Jun, Wan Park, Young Ho Kim, James S Malter, Byung Jo Moon.   

Abstract

Despite commonalities in signal transduction in osteoblasts from different species, the role of TGF-beta1 on bone formation remains elusive. In particular, the role of autocrine TGF-beta1 on human osteoblasts is largely unknown. Here we show the effect of TGF-beta1 knock-down on the proliferation and differentiation of osteoblasts induced by BMP2. Treatment with antisense TGF-beta1 moderately increased the rate of cell proliferation, which was completely reversed by the exogenous addition of TGF-beta1. Notably, TGF-beta1 blockade significantly enhanced BMP2-induced upregulation of mRNAs encoding osteopontin, type I collagen and Cbfa1, which was suppressed by exogenous TGF-beta1. Moreover, TGF-beta1 knock-down increased BMP2-induced phosphorylation of Smad1/5 as well as their nuclear import, which paralleled a reduction of inhibitory Smad6. These data suggest autocrine TGF-beta1 antagonizes BMP signaling through modulation of inducible Smad6 and the activity of BMP specific Smad1/5.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17359969     DOI: 10.1016/j.yexcr.2007.01.014

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Screen for reactivation of MeCP2 on the inactive X chromosome identifies the BMP/TGF-β superfamily as a regulator of XIST expression.

Authors:  Smitha Sripathy; Vid Leko; Robin L Adrianse; Taylor Loe; Eric J Foss; Emily Dalrymple; Uyen Lao; Tonibelle Gatbonton-Schwager; Kelly T Carter; Bernhard Payer; Patrick J Paddison; William M Grady; Jeannie T Lee; Marisa S Bartolomei; Antonio Bedalov
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-31       Impact factor: 11.205

2.  Fez function is required to maintain the size of the animal plate in the sea urchin embryo.

Authors:  Shunsuke Yaguchi; Junko Yaguchi; Zheng Wei; Yinhua Jin; Lynne M Angerer; Kazuo Inaba
Journal:  Development       Date:  2011-08-18       Impact factor: 6.868

3.  In vitro cell response on CP-Ti surfaces functionalized with TGF-β1 inhibitory peptides.

Authors:  Pablo Sevilla; Andrea Cirera; Javier Dotor; Francisco Javier Gil; Pablo Galindo-Moreno; Conrado Aparicio
Journal:  J Mater Sci Mater Med       Date:  2018-05-23       Impact factor: 3.896

4.  Coordinated gene expression during gilthead sea bream skeletogenesis and its disruption by nutritional hypervitaminosis A.

Authors:  Ignacio Fernández; Maria Darias; Karl B Andree; David Mazurais; Jose Luís Zambonino-Infante; Enric Gisbert
Journal:  BMC Dev Biol       Date:  2011-02-09       Impact factor: 1.978

5.  Stem cell property of postmigratory cranial neural crest cells and their utility in alveolar bone regeneration and tooth development.

Authors:  Il-Hyuk Chung; Takayoshi Yamaza; Hu Zhao; Pill-Hoon Choung; Songtao Shi; Yang Chai
Journal:  Stem Cells       Date:  2009-04       Impact factor: 6.277

6.  Signaling by TGF-betas in tubule cultures of adult rat testis.

Authors:  Kai-Hui Chan; Sebastian P Galuska; Pradeep Kumar Kudipudi; Mohammad Assad Riaz; Kate L Loveland; Lutz Konrad
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

7.  Expression of HOXC8 is inversely related to the progression and metastasis of pancreatic ductal adenocarcinoma.

Authors:  H Adwan; M Zhivkova-Galunska; R Georges; E Eyol; J Kleeff; N A Giese; H Friess; F Bergmann; M R Berger
Journal:  Br J Cancer       Date:  2011-06-28       Impact factor: 7.640

8.  Biofunctionalization with a TGFβ-1 Inhibitor Peptide in the Osseointegration of Synthetic Bone Grafts: An In Vivo Study in Beagle Dogs.

Authors:  Andrea Cirera; Maria Cristina Manzanares; Pablo Sevilla; Monica Ortiz-Hernandez; Pablo Galindo-Moreno; Javier Gil
Journal:  Materials (Basel)       Date:  2019-09-27       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.